Using health data to predict outcomes for childhood cancer survivors
Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes
This study is trying to see if health information shared by childhood cancer survivors can help predict their chances of facing future health problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 620 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | St. Jude Children's Research Hospital Academic / other |
| Locations | 1 site (Memphis, Tennessee) |
| Trial ID | NCT05342155 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect patient-generated health data (PGHD) from childhood cancer survivors to predict their risk of developing future health issues. Participants will report symptoms and other health-related information using a mobile health platform over a two-year period, with assessments occurring at multiple time points. The study focuses on integrating data related to physical activity, sleep behavior, and heart rate variability to develop risk prediction models that can improve survivorship care and outcomes.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18 and older who are at least five years post-diagnosis of pediatric cancer and currently not receiving cancer therapies.
Not a fit: Patients with severe neurocognitive impairments or those who cannot communicate in English may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the ability to predict and manage health issues in childhood cancer survivors, leading to improved quality of life.
How similar studies have performed: While the use of patient-generated health data is gaining traction, this specific approach to predicting outcomes in childhood cancer survivors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years of age at the time of study * Enrolled on SJLIFE * ≥5 years from initial diagnosis of pediatric cancer/malignancy * Currently not receiving cancer therapies * Access to web-enabled smartphone Exclusion Criteria: * Known severe neurocognitive impairment (e.g., estimated intelligence score \[FSIQ\] \<70), which requires proxies to complete daily symptom and PRO surveys; * \<3rd-grade reading level or not able to communicate in English; * Currently pregnant or reports planning to become pregnant in the next two years; * Lack of access to web-enabled smartphone, or not able to use/access internet from the device.
Where this trial is running
Memphis, Tennessee
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States (Recruiting)
Study contacts
- Principal investigator: I-Chang Huang, PhD — St. Jude Children's Research Hospital
- Study coordinator: I-Chang Huang, PhD
- Email: referralinfo@stjude.org
- Phone: 866-278-5833
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.